Tuberculosis Breakthrough: Bacteria Hijack Immune System to Thrive
Table of Contents
A new study reveals how Mycobacterium tuberculosis exploits a key immune receptor, dectin-1, to survive and replicate within host cells, offering a crucial insight into the enduring threat of this deadly disease.
Tuberculosis (TB) remains a global health crisis, and researchers have uncovered a surprising mechanism behind the bacterium’s resilience: it actively subverts the very immune system designed to protect against infection.
The Immune System’s Unexpected Weakness
Mycobacterium tuberculosis (MTB), the bacterium responsible for TB, typically infects individuals when inhaled and taken up by macrophages, specialized immune cells. These cells recognize MTB and initiate a cascade of immune responses, mediated by receptors on their surface. One such receptor, Dectin-1, is well-known for its role in fighting fungal infections. However, researchers have discovered that MTB doesn’t simply evade Dectin-1 – it exploits it.
“TB is a major killer worldwide, yet we still know very little about how it is so effective at causing infections, in both humans and in animals,” stated a senior researcher involved in the study. “Our discovery of a new mechanism by which Mycobacterium tuberculosis is able to subvert host immunity is a key step in understanding the basis of susceptibility to TB.”
How MTB Turns Defense into Prospect
Published in Science Immunology, the research details how MTB survives within host cells by specifically targeting Dectin-1. Instead of triggering a protective immune response, the bacterium utilizes the pathway activated by Dectin-1 to promote its own survival. Experiments demonstrated that when the Dectin-1 pathway was absent, both human and mouse cells were able to effectively control the MTB infection. Notably, mice genetically engineered to lack Dectin-1 exhibited substantially increased resistance to TB.
The team further identified that MTB produces a unique molecule, alpha-glucan, to specifically target Dectin-1 and induce these detrimental immune cell responses. This finding represents a paradigm shift in understanding how TB establishes itself and causes disease.
A Global Collaboration Yields Critical Insights
The collaborative effort, involving researchers from Osaka University, the University of Cape Town, the Francis Crick Institute, and others, underscores the importance of international partnerships in tackling complex global health challenges.
“this research is a true international collaboration, with each institution bringing a distinct area of expertise,” noted an associate professor from the University of Cape Town. “Its a fantastic exmaple of the global partnerships required to tackle some of the greatest health challenges of our time.”
Professor Sho Yamasaki of Osaka University explained the surprising nature of the findings: “Our results are surprising, because Dectin-1 is a key part of the body’s defence system to protect against fungal infections, yet we’ve shown it’s detrimental for MTB infections and actually promotes bacterial survival.”
Future Implications and Potential Treatments
This discovery opens up exciting new avenues for TB research and potential therapeutic interventions. Professor Gordon Brown, of the University of Exeter’s MRC Center for Medical Mycology, highlighted the potential for targeted therapies. “This discovery is the first step – and opens the door to exciting new prospects including, such as, if we could knock out this receptor in cattle to make them more resistant to infection.”
The study, titled ‘Mycobacterial α-glucans hijack Dectin-1 to facilitate intracellular bacterial survival’, provides a crucial foundation for developing novel strategies to combat this persistent and deadly disease.
https://www.science.org/doi/10.1126/sciimmunol.adw0732
